Workflow
IDEXX forecasts 2026 revenue, profit above estimates on strong demand for pet diagnostics
Reuters· 2026-02-02 13:12
Animal diagnostics maker IDEXX Laboratories on Monday forecast 2026 revenue and profit above Wall Street estimates, betting that resilient demand at veterinary clinics and higher testing per visit wil... ...
6 Key Signs You’re House Poor and Don’t Even Realize It
Yahoo Finance· 2026-02-02 13:11
Owning a home has long symbolized financial security, but in 2025’s high-cost environment, some Americans may find that their homes are actually straining their budgets. Being “house poor” doesn’t always mean you’re behind on payments; it can simply mean too much of your income goes toward your home, leaving too little for savings, emergencies or everyday life. Experts explained six key signs that you may be house poor without realizing it. 1. Your Housing Costs Exceed 30% of Your Income Financial plan ...
Ripple gains full EU electronic money licence in Luxembourg
Yahoo Finance· 2026-02-02 13:10
Group 1 - Ripple has secured full authorisation as an Electronic Money Institution (EMI) from Luxembourg's financial regulator, CSSF, after meeting all regulatory requirements [1] - The EU licence extends Ripple's regulatory footprint, adding to its existing EMI licence and Cryptoasset Registration from the UK's Financial Conduct Authority, bringing the total to over 75 licences globally [2] - The managing director for UK & Europe stated that the full EMI licence in the EU is a transformative milestone, enhancing Ripple's presence in European finance [2][3] Group 2 - Europe is a strategic priority for Ripple, and the new authorisation allows the company to scale its mission of providing compliant blockchain infrastructure to clients across the EU [3] - Ripple raised $500 million in November at a valuation of $40 billion, indicating strong investor confidence and regulatory progress [3][4] - The company has been active in acquisitions, agreeing to a $1 billion deal for GTreasury and a $200 million deal for Rail, enhancing its payment infrastructure [4][5]
INVESTOR DEADLINE: F5, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
Globenewswire· 2026-02-02 13:10
Core Viewpoint - The F5 class action lawsuit alleges that F5, Inc. and its executives misled investors regarding the company's revenue outlook and growth potential, particularly in light of a significant security incident that impacted its operations and stock price [1][4]. Company Overview - F5, Inc. is a global multi-cloud application security and delivery company that enables customers to deploy, secure, and operate applications both on-premises and via public cloud [3]. Allegations of the Lawsuit - The lawsuit claims that F5 created a false impression of having reliable information about its projected revenue and growth while downplaying risks associated with seasonality and macroeconomic factors [4]. - It is alleged that F5 was experiencing a significant security incident that jeopardized client security and the company's future prospects [4]. - On October 15, 2025, F5 disclosed a security breach involving a nation-state threat actor, leading to a nearly 14% drop in stock price over two trading days [5]. - Following the breach, F5 reported fourth quarter fiscal year 2025 results that fell significantly below market growth expectations for fiscal 2026, resulting in an 11% decline in stock price over two trading days [6]. Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased F5 securities during the Class Period to seek appointment as lead plaintiff in the class action lawsuit [7]. - The lead plaintiff represents the interests of all class members and can select a law firm to litigate the case [7]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [8].
Kuwait oil minister tells Reuters: We expect to issue tenders for Durra field with Saudi Arabia in 2026
Reuters· 2026-02-02 13:08
Kuwait's oil minister Tariq Al-Roumi told Reuters on Monday that he expects tenders for the Durra oil and gas field project, in cooperation with Saudi Arabia, to be launched this year. ...
Jim Cramer Defends Trump: “He Brings Down Prices”
247Wallst· 2026-02-02 13:07
For better or for worse, Mad Money's Jim Cramer cannot be accused of being politically partisan. Since admitting that he only cares about policies that help stocks make money in 2017, he has been consistently non- partisan about politicians and only critical about policies. In the case of President Trump, for example, Cramer has been supportive of measures like tax cuts and critical of tariffs. This is why Cramer took an unusual stance of defending President Trump on a recent Mad Money episode by exclaiming ...
NVIDIA Just Made Another Smart Bet on AI
247Wallst· 2026-02-02 13:07
Nvidia (NASDAQ:NVDA) just seems to keep the deals and partnerships coming. ...
Garrett Motion introduces breakthrough oil-free centrifugal compressor technology for HVAC systems at AHR Expo 2026 in Las Vegas
Globenewswire· 2026-02-02 13:06
Core Insights - Garrett Motion Inc. has introduced a breakthrough oil-free centrifugal compressor technology for HVAC systems, aiming to cover cooling demands from 7 to 500 Tons (25 to 1,750 kWc) [2][3] - The company plans to generate $1 billion in revenues outside its Turbo automotive business by 2030, leveraging proven automotive technologies for industrial HVAC applications [3] Technology and Innovation - The new HVAC compressor technology offers a superior alternative to existing solutions such as scroll, screw, and magnetic bearing-based compressors, utilizing efficient turbo machinery and high-speed electric motors [3] - The compressors are designed to enable significant energy savings of over 10% in real-life applications compared to current solutions [5] Sustainability and Cost Efficiency - Garrett's compressors support sustainability goals by facilitating the use of next-generation ultra-low GWP refrigerants and providing cost savings through lower energy consumption and reduced maintenance needs [4] - The compact and lightweight design allows for retrofitting onto existing installations, ensuring a fast payback for end users [4] Market Applications - The comprehensive portfolio of oil-free centrifugal compressors is tailored for various commercial HVAC needs, including rooftop units, chillers for comfort cooling, data center cooling, and battery energy storage applications [5] - Customer testing samples are currently available, with production set to begin in late 2026 [6]
Senseonics (SENS) Moves 5.3% Higher: Will This Strength Last?
ZACKS· 2026-02-02 13:05
Core Insights - Senseonics Holdings (SENS) shares increased by 5.3% to close at $7.33, supported by high trading volume, and have gained 26.1% over the past four weeks [1][2] Company Performance - The company achieved CE Mark approval for the Eversense 365 continuous glucose monitoring (CGM) system, which is the first one-year CGM and can integrate with compatible medical devices [2] - Senseonics is expected to report a quarterly loss of $0.43 per share, reflecting a year-over-year decline of 7.5%, while revenues are projected to be $14.2 million, representing a 71.1% increase from the previous year [3] Earnings Estimates - The consensus EPS estimate for Senseonics has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4] - The stock currently holds a Zacks Rank of 3 (Hold), suggesting a neutral outlook [4]
Largest Published Study of Molecular Residual Disease (MRD) in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence After Surgery to Support Timely Treatment Decisions
Businesswire· 2026-02-02 13:05
PALO ALTO, Calif. & ROCHESTER, Minn.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company and research collaborators at Mayo Clinic and the Alliance for Clinical Trials in Oncology today announced publication of the largest study to date evaluating circulating tumor DNA (ctDNA) for MRD detection in patients with resected stage III colon cancer after surgery and before adjuvant chemotherapy. Results of the study, published in the Journal of Clinical Oncology, show that d ...